Edwards Lifesciences Corp. (EW)

137.57
1.49 1.07
NYSE : Health Technology
Prev Close 139.06
Open 139.39
Day Low/High 136.50 / 139.98
52 Wk Low/High 100.20 / 143.22
Volume 1.41M
Avg Volume 1.34M
Exchange NYSE
Shares Outstanding 210.78M
Market Cap 28.93B
EPS 2.80
P/E Ratio 52.55
Div & Yield N.A. (N.A)

Latest News

9 Stocks Poised to Change Direction: Guess Which Way UPS Is Headed?

9 Stocks Poised to Change Direction: Guess Which Way UPS Is Headed?

These well-known names are showing signs of either bullish or bearish reversal patterns.

Edwards Lifesciences Takes Over #37 Spot From Vertex Pharmaceuticals

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp has taken over the #37 spot from Vertex Pharmaceuticals, Inc. , according to ETF Channel.

Regions Financial, Edwards Lifesciences: 'Mad Money' Lightning Round

Regions Financial, Edwards Lifesciences: 'Mad Money' Lightning Round

Jim Cramer focuses on Regions Financial, Edwards Lifesciences, Align Technology, Applied Materials, Qualys, HEICO and more.

Not Thankful for Fridays: Cramer's 'Mad Money' Recap (Friday 4/20/18)

Not Thankful for Fridays: Cramer's 'Mad Money' Recap (Friday 4/20/18)

Jim Cramer says analysts and trade woes put a damper on buying ahead of the weekend. So let's get the game plan for next week.

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

3 Large-Cap Healthcare Stocks You Must Buy Following the Market Pullback

Large-cap healthcare stocks, especially those in the medical technology sector, are one of the biggest losers in the recent market selloff.

Edwards Lifesciences Achieves #54 Analyst Rank, Surpassing Snap-On

Edwards Lifesciences Achieves #54 Analyst Rank, Surpassing Snap-On

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Edwards Lifesciences Corp has taken over the #54 spot from Snap-On, Inc. , according to ETF Channel.

Cramer: 10 Points to Consider

Cramer: 10 Points to Consider

Don't worry about missing anything, we haven't solved the bond conundrum and the evidence says we get to 3% with selloffs on the way.

7 Investment Themes You Can't Afford to Miss for 2018

7 Investment Themes You Can't Afford to Miss for 2018

The 'winning formula' for this year focuses on growth, size and foreign stocks, Jefferies says.

Marvell Technology, Albemarle, Dominion Energy: 'Mad Money' Lightning Round

Marvell Technology, Albemarle, Dominion Energy: 'Mad Money' Lightning Round

Jim Cramer is bullish on Marvell Technology, Albemarle, Dominion Energy, Best Buy, Houlihan Lokey.

Consumers Are Ready to Spend: Cramer's 'Mad Money' Recap (Tuesday 1/9/18)

Consumers Are Ready to Spend: Cramer's 'Mad Money' Recap (Tuesday 1/9/18)

Jim Cramer explains why some retailers are doing so well and how investors can take advantage of the opportunities.

Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program

Edwards Lifesciences' Board Approves New $1 Billion Share Repurchase Program

Company Also Enters Into Accelerated Share Repurchase Agreement

Edwards Acquires Harpoon Medical

Edwards Acquires Harpoon Medical

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

What it Takes to Power This Bull: Cramer's 'Mad Money' Recap (Thursday 11/30/17)

Lose the cynicism or you might miss the move. Jim Cramer outlines the reasons for these gains and why investors need to watch them.

Medtronic's Strong Q1 Helps Send Healthcare Stocks Higher

Medtronic's Strong Q1 Helps Send Healthcare Stocks Higher

The Health Care SPDR ETF (XLV) was rising nearly 1% in afternoon trading on Tuesday, boosted in part, by solid results from medical equipment company Medtronic.

Ollie's Bargain Outlet, Blackstone Group: 'Mad Money' Lightning Round

Ollie's Bargain Outlet, Blackstone Group: 'Mad Money' Lightning Round

Jim Cramer is bullish on Ollie's Bargain Outlet, Burlington Stores, Blackstone Group, and UnitedHealth Group.

Can You Recognize Growth?: Cramer's 'Mad Money' Recap (Tuesday 10/31/2017)

Can You Recognize Growth?: Cramer's 'Mad Money' Recap (Tuesday 10/31/2017)

Jim Cramer says the world's been starved for growth for ages, so suspend your disbelief and don't miss out on this economic opportunity.

String of Disappointing Earnings Leads Markets Into the Red

String of Disappointing Earnings Leads Markets Into the Red

Several firms reported both top and bottom line third-quarter misses, as the three major U.S. averages remain in the red on Wednesday.

12 Stocks This Top Research Firm Wants You to Buy Now

12 Stocks This Top Research Firm Wants You to Buy Now

These are the 12 best investment selections from Fundstrat that may provide investors with 'timely' long-term potential.

TheStreet Quant Rating: B (Buy)